当前位置:首页 > 股票大全 > 晨光生物 300138 财务分析

晨光生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

晨光生物(300138)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入1,732,327,232.516,871,515,007.685,169,444,187.283,668,696,988.23
营业总成本1,687,056,795.936,450,813,191.254,800,484,167.223,406,936,968.59
营业利润44,344,785.94548,324,537.43464,825,089.72353,976,021.44
利润总额44,253,527.86555,818,667.92471,149,241.11356,582,149.6
净利润32,993,385.92494,173,306.76416,111,137.75314,892,436.62
其他综合收益567,008.047,223,216.2713,422,891.2219,050,485.22
综合收益总额33,560,393.96501,396,523.03429,534,028.97333,942,921.84
晨光生物(300138)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计6,909,620,264.146,366,848,988.015,292,532,828.335,166,825,521.37
非流动资产合计2,171,111,056.872,172,731,507.622,137,135,551.842,073,026,992.99
资产总计9,080,731,321.018,539,580,495.637,429,668,380.177,239,852,514.36
流动负债合计4,297,453,012.063,952,021,753.843,265,999,836.693,316,065,570.6
非流动负债合计1,364,828,657.651,055,305,846.98607,496,639.89463,206,147.3
负债合计5,662,281,669.715,007,327,600.823,873,496,476.583,779,271,717.9
归属于母公司股东权益合计3,361,805,660.573,470,467,781.163,491,098,911.83,397,025,349.56
股东权益合计3,418,449,651.33,532,252,894.813,556,171,903.593,460,580,796.46
负债和股东权益合计9,080,731,321.018,539,580,495.637,429,668,380.177,239,852,514.36
晨光生物(300138)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计1,967,298,261.337,421,573,9985,222,452,862.693,779,502,687.51
经营活动现金流出小计1,769,866,737.488,010,043,170.694,226,814,257.193,096,938,223.56
经营活动产生的现金流量净额197,431,523.85-588,469,172.69995,638,605.5682,564,463.95
投资活动现金流入小计663,619,546.35196,709,230.871,030,026,484703,414,681.55
投资活动现金流出小计191,485,329.98644,976,7541,048,346,386.96586,229,504.22
投资活动产生的现金流量净额472,134,216.37-448,267,523.13-18,319,902.96117,185,177.33
筹资活动现金流入小计1,455,555,020.25,176,606,378.72,786,703,439.91,574,983,439.9
筹资活动现金流出小计989,394,544.83,879,789,977.942,497,544,246.881,596,588,554.02
筹资活动产生的现金流量净额466,160,475.41,296,816,400.76289,159,193.02-21,605,114.12
汇率变动对现金及现金等价物的影响-2,405,269.04-6,050,321.18-5,308,661.6534,315.2
现金及现金等价物净增加额1,133,320,946.58254,029,383.761,261,169,233.91778,178,842.36
期末现金及现金等价物余额2,218,585,909.31,085,264,962.722,092,404,812.871,609,414,421.32
晨光生物300138相关数据
今日股市大盘指数